Finsterer, J., & Zarrouk-Mahjoub, S. (2017). Costs for mitochondrial medicine will remain high as long as mitochondrial disorders are misdiagnosed()()()(). Mol Genet Metab Rep.
Citação norma ChicagoFinsterer, Josef, and Sinda Zarrouk-Mahjoub. "Costs for Mitochondrial Medicine Will Remain High As Long As Mitochondrial Disorders Are Misdiagnosed()()()()." Mol Genet Metab Rep 2017.
MLA CitationFinsterer, Josef, and Sinda Zarrouk-Mahjoub. "Costs for Mitochondrial Medicine Will Remain High As Long As Mitochondrial Disorders Are Misdiagnosed()()()()." Mol Genet Metab Rep 2017.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.